Ghrelin Aggravates Prostate Enlargement in Rats with Testosterone-Induced Benign Prostatic Hyperplasia, Stromal Cell Proliferation, and Smooth Muscle Contraction in Human Prostate Tissues

Ghrelin Aggravates Prostate Enlargement in Rats with Testosterone-Induced Benign Prostatic Hyperplasia, Stromal Cell Proliferation, and Smooth Muscle Contraction in Human Prostate Tissues

Epidemiologic studies revealed a context between lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) and metabolic syndrome. However, molecular mechanisms underlying this relationship are largely unknown. Prostate enlargement and increased prostate smooth muscle tone...

Full description

Bibliographic Details
Main Authors:	Xiaolong Wang, Yiming Wang, Christian Gratzke, Christian Sterr, Qingfeng Yu, Bingsheng Li, Frank Strittmatter, Annika Herlemann, Alexander Tamalunas, Beata Rutz, Anna Ciotkowska, Raphaela Waidelich, Chunxiao Liu, Christian G. Stief, Martin Hennenberg
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Oxidative Medicine and Cellular Longevity
Online Access:	http://dx.doi.org/10.1155/2019/4748312

Similar Items

P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate.
by: Yiming Wang, et al.
Published: (2016-01-01)

Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases
by: Martin Hennenberg, et al.
Published: (2018-06-01)

Concentration-dependent alpha1-Adrenoceptor Antagonism and Inhibition of Neurogenic Smooth Muscle Contraction by Mirabegron in the Human Prostate
by: Ru Huang, et al.
Published: (2021-06-01)

Inhibition of human prostate smooth muscle contraction by thalidomide: A novel remedy in LUTS?
by: A. Tamalunas, et al.
Published: (2020-07-01)

Honokiol, a constituent of Magnolia species, inhibits adrenergic contraction of human prostate strips and induces stromal cell death
by: Daniel Herrmann, et al.
Published: (2014-09-01)

Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle.
by: Martin Hennenberg, et al.
Published: (2012-01-01)

Inhibition of human prostate smooth muscle contraction by the integrin α2β1-selective inhibitor BTT3033 and the integrin-linked kinase inhibitor Cpd22
by: B. Li, et al.
Published: (2020-07-01)

Inhibition of Female and Male Human Detrusor Smooth Muscle Contraction by the Rac Inhibitors EHT1864 and NSC23766
by: Bingsheng Li, et al.
Published: (2020-04-01)

The STK-16 inhibitor STK16-IN-1 inhibits non-neurogenic/non-adrenergic smooth muscle contractions in the human prostate and the human male detrusor
by: B. Li, et al.
Published: (2020-07-01)

Carcinosarcoma of the Prostate Masquerading as Benign Prostatic Enlargement: Lesson Learned
by: Nivash Selvaraj, et al.
Published: (2021-01-01)

The surgical treatment of enlarged prostate
by: Rutherford, William Archibald
Published: (1899)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
by: Strittmatter F, et al.
Published: (2011-10-01)

Testosterone replacement and prostate cancer
by: Ranjith Ramasamy, et al.
Published: (2012-01-01)

Testosterone and benign prostatic hyperplasia
by: Thomas R Jarvis, et al.
Published: (2015-04-01)

The Efficiency of the Serum Prostate Specific Antigen Levels in Diagnosing Prostatic Enlargements
by: Ingle SP, et al.
Published: (2013-01-01)

Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.
by: Ayush Giri, et al.
Published: (2015-01-01)

Pharmacology of the lower urinary tract
by: Martin Hennenberg, et al.
Published: (2014-01-01)

Enlargement of the prostate and its operative treatment
by: Taylor, T.
Published: (1910)

Rac1 inhibition by EHT1864, NSC23766 or by knockdown of Rac1 expression reduces proliferation and contraction of human bladder smooth muscle cells
by: R. Wang, et al.
Published: (2020-07-01)

Effect of a Combination of Dutasteride and Parenteral Testosterone Undecanoate on Testosterone Deficiency Symptoms and Prostate in Patients with Testosterone Efficiency and Benign Prostatic Hyperplasia
by: Min Gu Park, et al.
Published: (2020-06-01)

Correlation between the severity of erectile dysfunction and prostate size in patients with benign prostatic enlargement
by: Kenenna Obiatuegwu, et al.
Published: (2021-02-01)

Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
by: Ali Atan, et al.
Published: (2013-01-01)

Comparison of the pre-treatment testosterone levels in benign prostatic hyperplasia and prostate cancer patients
by: D.E. Orakwe, et al.
Published: (2017-06-01)

Transurethral resection of prostate in benign prostatic enlargement with underactive bladder: A retrospective outcome analysis
by: Ashok Kumar Sokhal, et al.
Published: (2017-01-01)

Impact of the level of testosterone on the development of cancer of the prostate
by: A. V. Pechersky, et al.
Published: (2020-02-01)

Testosterone replacement therapy and the risk of prostate cancer
by: Daniel Warburton, et al.
Published: (2015-01-01)

Unmet Medical Needs of Patients with Benign Prostate Enlargement
by: Munjae Lee, et al.
Published: (2020-03-01)

Reduction of enlarged prostate decreases the incidence of inguinal hernia
by: Yu-Hua Fan, et al.
Published: (2015-06-01)

Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer
by: Weitao Song, et al.
Published: (2015-01-01)

The role of serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk
by: Cenk Gurbuz, et al.
Published: (2012-12-01)

Clinical and pathological observations on cases of prostatic enlargement (so called) with its complications, and on carcinomata of the prostate gland, simulating enlargement, with incidental remarks on treatment
by: Croll, Andrew
Published: (1899)

Safety and feasibility of thullium laser transurethral resection of prostate for the treatment of benign prostatic enlargement in overweight patients
by: Luca Carmignani, et al.
Published: (2019-07-01)

The value of intravesical prostatic protrusion in evaluation of bladder outlet obstruction from benign prostatic enlargement in Nigeria
by: C.A. Agbo, et al.
Published: (2018-12-01)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2021-07-01)

Prostate specific antigen and relative prostate weight data on effect of Tetracarpidium conophorum leaf extract on testosterone-induced benign prostatic hyperplasia
by: Omolola E. Omotosho, et al.
Published: (2018-10-01)

Inhibition of cholinergic, neurogenic, and non-cholinergic/non-neurogenic detrusor contractions by the Rac inhibitor EHT1864
by: B. Li, et al.
Published: (2020-07-01)

Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels.
by: Thomas J Walsh, et al.
Published: (2018-01-01)

Local epidemiology and resistance profiles in acute uncomplicated cystitis (AUC) in women: a prospective cohort study in an urban urological ambulatory setting
by: Michael Seitz, et al.
Published: (2017-10-01)

CHANGE IN TESTOSTERONE LEVELS IN ENDOSCOPIC OPERATIONS ON THE PROSTATE GLAND
by: E. A. Efremov, et al.
Published: (2018-06-01)

Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer
by: Michael A. Bell, et al.
Published: (2018-05-01)